July is Sarcoma Awareness Month! Every July, we honor, celebrate, and amplify the Sarcoma community in support of this rare cancer. As we begin Sarcoma Awareness Month, here are some statistics about the disease, per the Sarcoma Foundation of America: In recent year, sarcoma has comprised 1% of adult cancers diagnosed in the United States while also comprising 15 to 20% of childhood cancers. Latest estimates show that 17,560 people in the United States will be diagnosed with sarcoma and ~220,000 patients and families are living with sarcoma in a given year. There are so many ways to learn and get involved with this inspiring community! We can't wait to share more. #sarcoma #sarcomaawarenessmonth #orthopediconcology #oncology #musculoskeletaloncology #bonecancer #cancerawareness #rarecancer
Onkos Surgical’s Post
More Relevant Posts
-
Fast, sensitive, non-invasive. Liquid biopsy checks all the boxes. As a powerful alternative when tissue biopsy cannot be performed, liquid biopsy can shed light on the mutations driving cancer. This information can be especially critical for advanced cancers, enabling faster intervention and improving the odds for better patient outcomes. Find out more about liquid biopsy, the emerging guidelines regarding its use, the risk CHIP poses to interpretation, and how it can benefit patients throughout their cancer journey: 🔗 https://loom.ly/LjSTH-w #DataDrivenMedicine #LiquidBiopsy #Oncology #PrecisionOncology #CancerGenomics
To view or add a comment, sign in
-
"Nuclear medicine specialist with a focus on musculoskeletal, cardiovascular, parathyroid and infection-inflammation imaging."
Excited to share our recent image of interest on [18F]FDG PET/CT in inflammatory breast cancer (IBC). Our key findings: -PET/CT excelled in detecting distant metastases -Enabled precise treatment response monitoring -Revealed an atypically extensive inflammatory component This interesting image highlights PET/CT's crucial role in IBC management, from initial staging to treatment assessment. More info: https://lnkd.in/dhFwYTdf #BreastCancer #PETCTImaging #OncologyResearch #MolecularImaging #InflammatoryBreastCancer #NuclearMedicine #CancerImaging #PrecisionOncology #MedicalPhysics #ClinicalOncology #WomensHealth #CancerCare #OncologyImaging
To view or add a comment, sign in
-
Human Genomics Student| Exploring the Code of Life for a Healthier Future 🧬| Igniting Innovation for Tomorrow's Health Paradigm
Exciting advancements in liquid biopsy for cancer detection! See how isolating WBC DNA can help avoid CHIP mutations and about cell-free DNA , revolutionizing precision medicine. #LiquidBiopsy #Genetics #Genomics #CancerResearch #PrecisionMedicine #CellFreeDNA #WBCDNA #PrecisionOncology #GeneticTesting #CancerAwareness #MedicalInnovation #ResearchAdvancements
Fast, sensitive, non-invasive. Liquid biopsy checks all the boxes. As a powerful alternative when tissue biopsy cannot be performed, liquid biopsy can shed light on the mutations driving cancer. This information can be especially critical for advanced cancers, enabling faster intervention and improving the odds for better patient outcomes. Find out more about liquid biopsy, the emerging guidelines regarding its use, the risk CHIP poses to interpretation, and how it can benefit patients throughout their cancer journey: 🔗 https://loom.ly/LjSTH-w #DataDrivenMedicine #LiquidBiopsy #Oncology #PrecisionOncology #CancerGenomics
To view or add a comment, sign in
-
MBA, MSc, PhD. Passion for Healthcare, Biotech and Pharma. Microbiologist by degree, Business Leader by vocation. Transformation Enthusiast. Molecular Diagnostics I Oncology I Rare Diseases I Genetics I Data Driven | IVD
📢 Exciting news! 🌟 Introducing a groundbreaking solution for liquid biopsy! 🧪🔬 by SOPHiA GENETICS 🧬 🔹 Liquid biopsy has revolutionized the field of cancer diagnostics by offering a non-invasive and comprehensive approach. It allows for the detection and monitoring of genetic alterations and tumor-derived materials in body fluids, such as blood or urine. 🔹 We thrilled to announce the launch of our new solution, which takes liquid biopsy to the next level. With cutting-edge technology and advanced algorithms, our solution provides highly accurate and reliable results, enabling early detection and personalized treatment strategies for patients. 🔹 By analyzing circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other biomarkers, our solution offers a comprehensive analysis of tumor characteristics, including genetic mutations, tumor heterogeneity, and treatment response. This empowers oncologists with valuable insights to make informed decisions and tailor treatment plans accordingly. 🔹 Additionally, our solution is designed to be user-friendly, ensuring seamless integration into clinical workflows. It combines efficiency, speed, and precision, making it an indispensable tool for oncology professionals and improving patient outcomes. 🔹 We are proud to contribute to the advancement of liquid biopsy technology and its potential to transform cancer care. Stay tuned for more updates as we continue to innovate and make a positive impact in the field of precision medicine. #LiquidBiopsy #CancerDiagnostics #PrecisionMedicine #Innovation #HealthcareRevolution #sophiagenetics
Fast, sensitive, non-invasive. Liquid biopsy checks all the boxes. As a powerful alternative when tissue biopsy cannot be performed, liquid biopsy can shed light on the mutations driving cancer. This information can be especially critical for advanced cancers, enabling faster intervention and improving the odds for better patient outcomes. Find out more about liquid biopsy, the emerging guidelines regarding its use, the risk CHIP poses to interpretation, and how it can benefit patients throughout their cancer journey: 🔗 https://loom.ly/LjSTH-w #DataDrivenMedicine #LiquidBiopsy #Oncology #PrecisionOncology #CancerGenomics
To view or add a comment, sign in
-
Even low dose cisplatin has an impact on sensorineural hearing loss - Sandro Porceddu Sandro Porceddu, Director of Radiation Oncology at Peter MacCallum Cancer Centre, highlighted key findings presented by Laurelie Wishart at the ANZHNCS ASM. The research from the TROG 12.01 study on low-risk HPV oropharyngeal cancer indicates that even low doses of cisplatin can affect sensorineural hearing loss, though the impact is notably less than with higher doses. It is crucial for patients undergoing low dose cisplatin treatment to be assessed and advised on potential hearing loss. https://lnkd.in/eDk5VmwU #Oncology #Cancer #OncoDaily #CancerTreatment
To view or add a comment, sign in
-
High precision screening
#artificialintelligence #breastcancer #cancerresearch #oncology Screening #mammogram of a 57-year-old woman where the #AI automatically flagged a suspicious lesion with a malignancy score of 89/100. Due to the high score, the mammogram was reviewed by two breast radiologists who agreed with the AI on the finding. Subsequent diagnostics revealed an invasive breast cancer. Photo: Department of Breast Examination Herlev Gentofte Hospital
To view or add a comment, sign in
-
Women Imaging Unit, Kasr Al-Ainy Hospital - How AI can enhance mammogram readings The Women Imaging Unit at Kasr Al-Ainy Hospital is hosting a workshop on the role of AI in improving mammogram readings. This session, part of the Baheya Foundation Breast Cancer Conference (BBCC), will explore the benefits of contrast mammography and the use of tomosynthesis in screening. https://lnkd.in/erafvyqK #OncoDaily #Oncology #Cancer #Health #Medicine #BreastCancer #Mammography
To view or add a comment, sign in
-
Exploring Salvage Surgeries in Resource-Limited Settings Join us for an insightful discussion between Dr. Lista Paul, Specialist in Surgical Oncology at MVR Cancer Centre and Research Institute, and Padma Shri Dr. Ravi Kannan R, Director of Cachar Cancer Hospital & Research Centre, Silchar. In this compelling interview, they explore the critical role and challenges of salvage surgeries in resource-limited settings. As pioneers in the field, Dr. Ravi Kannan shares his expertise on innovative approaches, the impact of limited resources on surgical outcomes, and the importance of patient-centered care. This conversation highlights their shared commitment to advancing cancer treatment accessibility and the necessity of adapting surgical techniques to local contexts. #SalvageSurgery #Oncology #SurgicalInnovation #CancerCare #ResourceLimitedSettings #PatientCenteredCare #HealthcareAccessibility #MVRCCRI #CacharCancerHospital #CancerTreatment #OncologyExperts #SurgicalOncology
To view or add a comment, sign in
-
Explore the transformative impact of MammaTyper® for breast cancer clinicians and patients in our latest short film. Renowned experts in the field delve into key benefits, highlighting its robust evidence base, affordability, and efficiency. MammaTyper® accurately matches breast cancer patients with life-saving treatment, as emphasized by Dr. Dario de Biase: "MammaTyper® can analyze a wide array of markers simultaneously, eliminating the need for sequential analysis." Join the conversation: #CancerDiagnostics #Pathology #Oncology #HealthInnovation
To view or add a comment, sign in
-
We're happy to be here on the second day of #ESMOBreast24. Yesterday was great and we're looking forward to talking to even more clinicians and experts. We'd love to chat more about: Ki67 as a predictor of recurrence-free survival in breast cancer. #BreastCancer #Oncology
To view or add a comment, sign in
9,826 followers